This post covers some of the recommendations and advices of the Indian brokerage and research firms that came out in the first week of March. This is a follow up to my first post where I started tracking the recommendations from Indian brokerage and research firms.
In the last week - Aurobindo Pharma had two BUY calls, a number of IT companies also had a BUY and there was one REDUCE for Ranbaxy. The following is the list
| Date | Brokerage/Research Firm Name | Stock | Recommendation | Target | Price on the date of recommendation |
| 5-Mar-10 | Prabhudas Lilladher | Infosys | BUY | 3,250 | |
| 5-Mar-10 | Firstcall Research | NIIT | HOLD | 76 | 66.5 |
| 5-Mar-10 | Firstcall Research | Bilpower | HOLD | 205 | 177.65 |
| 5-Mar-10 | Reliance Securities | Dishman Pharma | HOLD | 238 | 208 |
| 4-Mar-10 | Firstcall Research | SREI Infra | BUY | 90 | 73.45 |
| 4-Mar-10 | Firstcall Research | Mundra Port | BUY | 790 | 709 |
| 5-Mar-10 | Karvy | Inox Leisure | MARKET PERFORMER | 79 | |
| 3-Mar-10 | Sunidhi Securities | KPIT Cummins | BUY | 140 | 112 |
| 4-Mar-10 | Angel Securities | Balrampur Chini | NEUTRAL | ||
| 3-Mar-10 | Firstcall Research | Jyoti Structures | BUY | 200 | 161 |
| 3-Mar-10 | Firstcall Research | Tata Power | HOLD | 1499 | |
| 3-Mar-10 | Emkay | South Indian Bank | BUY | 180 | |
| 3-Mar-10 | SKP Research | Aurobindo Pharma | BUY | 1800 | |
| 3-Mar-10 | Angel Securities | Ranbaxy Labs | REDUCE | 445 | |
| 3-Mar-10 | Anand Rathi | Pratibha Industries | BUY | 501 | 350 |
| 3-Mar-10 | Hem Securities | Videocon Ind | BUY | 280 | |
| 2-Mar-10 | Motilal Oswal | Financial Tech | BUY | 1822 | |
| 3-Mar-10 | Karvy | Aurobindo Pharma | BUY | 1283 | 970 |
| 26-Feb-10 | Angel Securities | Tata Motor | BUY | 942 | |
RK
No comments:
Post a Comment